Table 1.
Participant characteristics.
| Variable | |
|---|---|
| Age (yr) | 63 ± 8 |
| Height (m) | 1.75 ± 0.07 |
| Weight (kg) | 87.9 ± 17.0 |
| BMI (kg·m−2) | 28.6 ± 4.4 |
| Cardiorespiratory assessment | |
| VO2 peak (mL·kg−1·min−1) | 21.2 ± 5.2 |
| Peak heart rate (bpm) | 126 ± 21 |
| CAD history (number) | |
| MI | 13 |
| PCI | 13 |
| CABG | 5 |
| Medication classification (number) | |
| ACE inhibitors | 13 |
| Antiplatelets | 19 |
| β-blockers | 15 |
| Calcium channel blockers | 2 |
| Statins | 18 |
| Time since CAD event (days) | 156 ± 43 |
Data expressed as mean ± SD. ACE: angiotensin-converting enzyme.
BMI: body mass index.